Vision RT and Accuray launch first clinical use of AlignRT InBore on Helical Platform. By News Release Published Date: June 22, 2026 Vision RT and Accuray have announced a significant milestone in the clinical implementation of their AlignRT InBore technology, now successfully utilized on the Accuray Helical Platform. Clinique Générale-Beaulieu, a member of the Swiss Medical Network, is the inaugural institution to employ this innovative solution, setting a precedent in the global medical community. The Swiss Medical Network, comprising three sites and serving approximately 900 patients annually, intends to expand the application of AlignRT InBore for patients undergoing treatment for breast, prostate, gastrointestinal, and secondary cancers. This integration marks an advancement in bore-based helical radiotherapy available at the network's facilities. The AlignRT InBore system combines Vision RT's ceiling-mounted AlignRT camera system, used for patient setup, with a specialized multi-camera configuration mounted inside the treatment bore. This strategic combination ensures that patient visibility and tracking remain uninterrupted during setup, imaging, and treatment phases. Commenting on this development, Vision RT CEO Dr. Norman Smith stated, "AlignRT InBore on the Accuray Helical Platform represents a step further in our mission to make surface guidance universal across radiation therapy." Designed specifically for the Accuray Helical Platform, AlignRT InBore incorporates a 3 mm-thick ring within the bore, facilitating seamless integration into the treatment environment while ensuring continuous surface tracking. Piyush Pratap Singh, Director of Product Marketing at Accuray, emphasized the system's capacity to enhance treatment precision and operational efficiency, noting: "Bringing AlignRT InBore to the Accuray Helical Platform reflects our commitment to expanding a vendor-neutral ecosystem that supports advanced treatment workflows." Professor Oscar Matzinger, Medical Director of Radio-Oncology and Chief Medical Officer of the Swiss Medical Network, expressed pride in their pioneering role, stating, "This achievement reflects the successful collaboration between Vision RT, Accuray, and our department. By enabling continuous patient monitoring and supporting breath-hold treatments, this innovative technology complements the precision of Accuray helical delivery and enhances treatment quality and safety." This integration of AlignRT InBore reaffirms Vision RT's commitment to enhancing radiation therapy for optimized patient care, encompassing simulation, planning, treatment, and dosing processes.